Flu shot: Seqirus presents absolute efficacy data on cell-based quadrivalent influenza vaccine
by Press Release from Outbreak News Today on (#59PNZ)
A global leader in influenza prevention, Seqirus presented today absolute efficacy data on the company's cell-based quadrivalent influenza vaccine (QIVc) from a randomized controlled trial (RCT) which met its primary endpoint in children and adolescents between >=2 to <18 years of age over three influenza seasons. This study represents the first absolute efficacy study of [...]
The post Flu shot: Seqirus presents absolute efficacy data on cell-based quadrivalent influenza vaccine appeared first on Outbreak News Today.